JP2022023958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022023958A5 JP2022023958A5 JP2021178868A JP2021178868A JP2022023958A5 JP 2022023958 A5 JP2022023958 A5 JP 2022023958A5 JP 2021178868 A JP2021178868 A JP 2021178868A JP 2021178868 A JP2021178868 A JP 2021178868A JP 2022023958 A5 JP2022023958 A5 JP 2022023958A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl group
- halogen atom
- hydrogen atom
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020008757 | 2020-01-22 | ||
| JP2020008757 | 2020-01-22 | ||
| PCT/JP2021/002088 WO2021149776A1 (ja) | 2020-01-22 | 2021-01-21 | 抗腫瘍活性を有するアリールアミド誘導体 |
| JP2021536299A JP6971432B1 (ja) | 2020-01-22 | 2021-01-21 | 抗腫瘍活性を有するアリールアミド誘導体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536299A Division JP6971432B1 (ja) | 2020-01-22 | 2021-01-21 | 抗腫瘍活性を有するアリールアミド誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022023958A JP2022023958A (ja) | 2022-02-08 |
| JP2022023958A5 true JP2022023958A5 (enExample) | 2024-01-30 |
| JP7693513B2 JP7693513B2 (ja) | 2025-06-17 |
Family
ID=76992539
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536299A Active JP6971432B1 (ja) | 2020-01-22 | 2021-01-21 | 抗腫瘍活性を有するアリールアミド誘導体 |
| JP2021178868A Active JP7693513B2 (ja) | 2020-01-22 | 2021-11-01 | 抗腫瘍活性を有するアリールアミド誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536299A Active JP6971432B1 (ja) | 2020-01-22 | 2021-01-21 | 抗腫瘍活性を有するアリールアミド誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11964950B2 (enExample) |
| EP (1) | EP4094804B1 (enExample) |
| JP (2) | JP6971432B1 (enExample) |
| KR (2) | KR102473971B1 (enExample) |
| CN (1) | CN114929669B (enExample) |
| AR (1) | AR121078A1 (enExample) |
| AU (1) | AU2021211553A1 (enExample) |
| BR (1) | BR112022009518A2 (enExample) |
| CA (1) | CA3168788A1 (enExample) |
| CL (1) | CL2022001938A1 (enExample) |
| CO (1) | CO2022011429A2 (enExample) |
| CR (1) | CR20220390A (enExample) |
| IL (1) | IL294916A (enExample) |
| MX (1) | MX2022008722A (enExample) |
| PE (1) | PE20230239A1 (enExample) |
| TW (2) | TW202313562A (enExample) |
| WO (1) | WO2021149776A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA53172A (fr) | 2018-07-20 | 2021-05-26 | Hoffmann La Roche | Composés de sulfonimidamide en tant qu'inhibiteurs de l'activité de l'interleukine 1 |
| JP7582694B2 (ja) | 2020-01-10 | 2024-11-13 | イミューニヤリング コーポレーション | Ｍｅｋ阻害剤及びその治療的使用 |
| AR121078A1 (es) | 2020-01-22 | 2022-04-13 | Chugai Pharmaceutical Co Ltd | Derivados de arilamida con actividad antitumoral |
| WO2022018875A1 (ja) * | 2020-07-22 | 2022-01-27 | 中外製薬株式会社 | アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 |
| JP7022873B1 (ja) * | 2020-07-22 | 2022-02-18 | 中外製薬株式会社 | アリールアミド誘導体を含む組成物 |
| JP2023553866A (ja) | 2020-12-02 | 2023-12-26 | イケナ オンコロジー， インコーポレイテッド | Ｔｅａｄ阻害剤、及びその使用 |
| WO2022120353A1 (en) | 2020-12-02 | 2022-06-09 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
| US20240261288A1 (en) | 2021-01-25 | 2024-08-08 | lkena Oncology, Inc. | Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhibitor and/or mek inhibitor for use in the treatment of lung cancer |
| KR102671612B1 (ko) * | 2021-07-21 | 2024-05-31 | 추가이 세이야쿠 가부시키가이샤 | 아릴아마이드 유도체의 제조 방법 |
| WO2023114984A1 (en) | 2021-12-17 | 2023-06-22 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
| IL313434A (en) | 2022-01-21 | 2024-08-01 | Chugai Pharmaceutical Co Ltd | Medicine for treating or preventing cancer |
| WO2023204259A1 (ja) | 2022-04-20 | 2023-10-26 | 中外製薬株式会社 | がんの治療又は予防用医薬 |
| WO2024002210A1 (zh) * | 2022-06-30 | 2024-01-04 | 上海喆邺生物科技有限公司 | 一种芳香酰胺类衍生物及其在抗肿瘤药物中的应用 |
| AR129187A1 (es) * | 2022-07-08 | 2024-07-24 | Nested Therapeutics Inc | Inhibidores de proteína quinasas activadas por mitógeno (mek) |
| WO2025007811A1 (zh) * | 2023-07-06 | 2025-01-09 | 成都华健未来科技有限公司 | 一类芳香酰胺类衍生物及其用途 |
| WO2025146040A1 (zh) * | 2024-01-01 | 2025-07-10 | 华健未来（成都）科技股份有限公司 | 芳香酰肼类衍生物及其医药用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2594720Y2 (ja) | 1993-03-22 | 1999-05-10 | 株式会社アーテックスズキ | 連結式キャビネット |
| JP4931419B2 (ja) | 2003-09-19 | 2012-05-16 | 中外製薬株式会社 | 新規４−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのｍｅｋ阻害剤としての使用 |
| CN1905873A (zh) * | 2003-11-19 | 2007-01-31 | 阵列生物制药公司 | Mek的杂环抑制剂及其使用方法 |
| US7732616B2 (en) * | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
| MY144232A (en) * | 2004-07-26 | 2011-08-15 | Chugai Pharmaceutical Co Ltd | 5-substituted-2-phenylamino benzamides as mek inhibitors |
| EP1922307B1 (en) | 2005-05-18 | 2011-12-28 | Array Biopharma, Inc. | Heterocyclic inhibitors of mek and methods of use thereof |
| AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| CN101432281B (zh) * | 2006-04-19 | 2013-08-28 | 诺瓦提斯公司 | 6-0-取代的苯并*唑和苯并噻唑化合物以及抑制csf-1r信号传导的方法 |
| EP2155659A1 (en) | 2007-05-11 | 2010-02-24 | Bayer Schering Pharma Aktiengesellschaft | Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| CA2720818A1 (en) * | 2008-04-22 | 2009-10-29 | Marion Hitchcock | Substituted phenoxybenzamides |
| US8993630B2 (en) * | 2008-11-10 | 2015-03-31 | Bayer Intellectual Property Gmbh | Substituted sulphonamido phenoxybenzamides |
| JP6075621B2 (ja) | 2010-08-10 | 2017-02-08 | 塩野義製薬株式会社 | 新規複素環誘導体およびそれらを含有する医薬組成物 |
| US20130123255A1 (en) | 2011-11-10 | 2013-05-16 | Chugai Seiyaku Kabushiki Kaisha | Combination of a pi3k inhibitor and a mek inhibitor |
| JP2016034900A (ja) | 2012-11-26 | 2016-03-17 | 中外製薬株式会社 | ５−置換−２−フェニルアミノ−ベンズアミド類の製造方法 |
| CA2901613C (en) | 2013-03-13 | 2020-10-20 | The Regents Of The University Of Michigan | Dual mek/pi3k inhibitors and therapeutic methods using the same |
| US20160222014A1 (en) * | 2013-09-10 | 2016-08-04 | Asana Biosciences, Llc | Compounds for regulating fak and/or src pathways |
| JP6403172B2 (ja) * | 2013-10-25 | 2018-10-10 | シャンハイ ヘンルイ ファーマスーティカル カンパニー リミテッドＳｈａｎｇｈａｉ Ｈｅｎｇｒｕｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． | ピリジンのケトン誘導体、それらの製造方法、およびそれらの医薬適用 |
| CN109988105A (zh) | 2014-01-27 | 2019-07-09 | 天津滨江药物研发有限公司 | 作为蛋白激酶抑制剂的氮杂环类化合物及其制备方法 |
| CN105384738B (zh) | 2014-08-21 | 2017-08-29 | 上海科州药物研发有限公司 | 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途 |
| AR121078A1 (es) | 2020-01-22 | 2022-04-13 | Chugai Pharmaceutical Co Ltd | Derivados de arilamida con actividad antitumoral |
| JP7022873B1 (ja) | 2020-07-22 | 2022-02-18 | 中外製薬株式会社 | アリールアミド誘導体を含む組成物 |
-
2021
- 2021-01-20 AR ARP210100120A patent/AR121078A1/es unknown
- 2021-01-21 WO PCT/JP2021/002088 patent/WO2021149776A1/ja not_active Ceased
- 2021-01-21 AU AU2021211553A patent/AU2021211553A1/en active Pending
- 2021-01-21 KR KR1020227002880A patent/KR102473971B1/ko active Active
- 2021-01-21 TW TW111146325A patent/TW202313562A/zh unknown
- 2021-01-21 CA CA3168788A patent/CA3168788A1/en active Pending
- 2021-01-21 CR CR20220390A patent/CR20220390A/es unknown
- 2021-01-21 PE PE2022001439A patent/PE20230239A1/es unknown
- 2021-01-21 JP JP2021536299A patent/JP6971432B1/ja active Active
- 2021-01-21 BR BR112022009518A patent/BR112022009518A2/pt unknown
- 2021-01-21 KR KR1020227041183A patent/KR102904379B1/ko active Active
- 2021-01-21 IL IL294916A patent/IL294916A/en unknown
- 2021-01-21 MX MX2022008722A patent/MX2022008722A/es unknown
- 2021-01-21 EP EP21744061.9A patent/EP4094804B1/en active Active
- 2021-01-21 TW TW110102277A patent/TWI788763B/zh active
- 2021-01-21 CN CN202180008024.XA patent/CN114929669B/zh active Active
- 2021-11-01 JP JP2021178868A patent/JP7693513B2/ja active Active
-
2022
- 2022-07-19 CL CL2022001938A patent/CL2022001938A1/es unknown
- 2022-07-20 US US17/869,226 patent/US11964950B2/en active Active
- 2022-08-12 CO CONC2022/0011429A patent/CO2022011429A2/es unknown
-
2024
- 2024-03-18 US US18/608,369 patent/US20240246922A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022023958A5 (enExample) | ||
| AR049446A1 (es) | Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados | |
| JP2019104748A5 (enExample) | ||
| JP2013512277A5 (enExample) | ||
| JP2010527983A5 (enExample) | ||
| RU2021139070A (ru) | Ингибиторы ERBB/BTK | |
| JP2016515560A5 (enExample) | ||
| JP2014516931A5 (enExample) | ||
| NO20064133L (no) | 5,6-dialkyl-7-amino-triazolpyrimidiner, fremgangsmate for fremstilling- av dem, deres anvendelse for a bekjempe skadelig sopp, og midler som inneholder disse forbindelsene | |
| EP2361503A3 (en) | N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same | |
| JP2012513416A5 (enExample) | ||
| JP2012092103A5 (enExample) | ||
| JP2016540742A5 (enExample) | ||
| JP2020529994A5 (enExample) | ||
| RU2015117251A (ru) | Новые соединения | |
| JP2019501130A5 (enExample) | ||
| JP2013518832A5 (enExample) | ||
| JP2015536947A5 (enExample) | ||
| JP2018502101A5 (enExample) | ||
| JP2011516511A5 (enExample) | ||
| JP2004518767A5 (enExample) | ||
| RU2012144438A (ru) | Производные 1-(2-фторбифенил-4-ил)-алкилкарбоновой кислоты для лечения транстиретинового амилоидоза | |
| JP2017522304A5 (enExample) | ||
| JP2020505440A5 (enExample) | ||
| RU2012150799A (ru) | Композиция для борьбы с заболеваниями растений и ее применение |